GC in excess exerts diabetogenic actions that include the increase in plasma triacylglycerol and NEFA levels and the reduction in peripheral insulin sensitivity [2–5, 16, 17], accompanied by an increase in blood glucose levels and the presence of glucose intolerance [2–7, 16, 17]. This evidence concerns the gene INS and Glucose intolerance.